Lifeline Scientific, Inc. (LSI.L) reported that its full-year 2011 net income attributable to co. increased to $3.47 million from $2.20 million last year. On a per share basis, earnings was $0.17 versus 0.12 year-ago.
For the twelve months, net income totaled $3.27 million compared to $1.99 million previous year.
Operating profit for the period decreased to $1.9 million from $4.5 million prior year reflecting planned strategic investments in product development and geographic expansion.
The company's total revenue advanced to $25.39 million from year ago's $23.17 million, primarily due to increased unit sales of LifePort Kidney Transporter and a significant increase in sales of solutions and consumable products.
Click here to receive FREE breaking news email alerts for Lifeline Scientific and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org